Since overactivation of the Hippo/YAP axis was observed in most PAAD samples, blocking the interaction between YAP and TEAD might be a promising approach for cancers driven by the Hippo signaling pathway [40, 41]. The gene discussed is YAP1; the disease is pancreatic adenocarcinoma.